The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabozantinib (Cabo) in advanced non-clear cell renal cell carcinoma (nccRCC): A retrospective multicenter analysis.
 
Nieves Martinez Chanza
No Relationships to Disclose
 
Dominick Bossé
No Relationships to Disclose
 
Mehmet Asim Bilen
Consulting or Advisory Role - Exelixis; Sanofi
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Nektar (Inst); Peleton (Inst); Pfizer (Inst); Tricon Pharmaceuticals (Inst)
 
Daniel M. Geynisman
Consulting or Advisory Role - Exelixis; Novartis; Pfizer
Research Funding - Genentech (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst)
 
Archana Balakrishnan
No Relationships to Disclose
 
Rohit K. Jain
No Relationships to Disclose
 
I. Alex Bowman
No Relationships to Disclose
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Castle Biosciences; Eisai; Exelixis; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Newlink Genetics
 
Vivek Narayan
No Relationships to Disclose
 
Benoit Beuselinck
Speakers' Bureau - Amgen; Ipsen; Pfizer
Research Funding - Pfizer
 
Neeraj Agarwal
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Cerulean Pharma; Clovis Oncology; Eisai; EMD Serono; Exelixis; Genentech/Roche; Medivation/Astellas; Merck; Nektar; Novartis; Pfizer
Research Funding - Amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Rana R. McKay
Research Funding - Bayer (Inst); Pfizer (Inst)
 
Joann Hsu
No Relationships to Disclose
 
Sumit Shah
No Relationships to Disclose
 
Abhishek Tripathi
No Relationships to Disclose
 
Elaine Tat Lam
Honoraria - Astellas Medivation
Consulting or Advisory Role - Calithera Biosciences
Research Funding - Advaxis; Argos Therapeutics; Astellas Medivation; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Janssen; Merck; Peloton Therapeutics; Pfizer; Roche
 
Tracy Lynn Rose
Research Funding - Roche/Genentech; X4 Pharma
 
Benedito A. Carneiro
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Pfizer; UpToDate
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Caris Life Sciences; Fujifilm; Genentech/Roche; HERON; Pfizer; Tolero Pharmaceuticals
Speakers' Bureau - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Sanofi
Research Funding - Endocyte (Inst); Merck (Inst); Suzhou Kintor Pharmaceuticals (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer/Onyx; Exelixis; Genentech/Roche; Pfizer; US Oncology
 
Lauren Christine Harshman
Consulting or Advisory Role - Bayer; Corvus Pharmaceuticals; Exelixis; Genentech; KEW; Medivation/Astellas; Merck; Pfizer; Theragene
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Medivation/Astellas (Inst); Merck (Inst); Pfizer (Inst); Sotio (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Bayer